safe@home: effectiveness and cost effectiveness of telemonitoring and virtual care supported by primary care for people living with chronic disease in low socioeconomic neighbourhoods for reducing ambulance ramping, readmission and GP clinic block.

The safe@home project is a solution! safe@home, will be co-designed, patient and family- centred using a prospective, non-blinded pragmatic randomised controlled trial to evaluate home telemonitoring supported by primary care for patients living with chronic disease in low socio-economic neighborhoods, evaluating the effectiveness and cost cost-effectiveness of reducing emergency department (ED) presentations (ambulance ramping), readmission (hospital avoidance), out-of-hospital death and improving access to primary care (clinic block) and self-care.